Alzheimer's Disease
Researchers used the world's most powerful MRI to get brain scans that are 10 times as detailed as a hospital MRI — take a look
Researchers unveiled images of the brain from the world's most powerful MRI, which could lead to breakthroughs in treating Alzheimer's and Parkinson's.
Chris Hemsworth shares 4 things he does for longevity and to protect his brain health after discovering his Alzheimer's risk
Chris Hemsworth found out while filming his docuseries "Limitless" that he has a gene that may make him eight to 10 times more likely to develop Alzheimer's.
An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly
In a late-stage trial, Eli Lilly's experimental Alzheimer's treatment slowed the rate of cognitive decline in Alzheimer's patients by 35%.
An MIT neuroscientist says 'routine' and 'discipline' are the keys to preserving memory and staving off dementia
MIT neuroscientist Li-Huei Tsai said people already know the main things they need to do to stay mentally healthy — they just need to carry them out.
MIT neuroscientists are testing a headset that uses a 'disco' of light and sound to treat Alzheimer's disease
Cognito Therapeutics just raised $73 million to test its headset in 500 patients with Alzheimer's disease.
Advertisement
Advertisement
The Mediterranean diet may reduce your risk of Alzheimer's thanks to staples like leafy greens and nuts, study finds
People who eat more leafy greens have healthier brains, the equivalent nearly two decades younger than peers who eat fewer veggies, study suggests.
Inside the 'doomsday' layoffs at Goldman Sachs
In Insider Weekly: We talk about Goldman Sachs' brutal layoffs, why paid sabbaticals are a good thing for everyone, and a new economic agenda.
We read through the 45-page congressional investigation into Biogen's Alzheimer's drug. Here are the 3 most shocking takeaways.
The investigation found that Biogen knew the drug's hefty price tag would make the medication inaccessible to many patients.
This Alzheimer’s drug slowed cognitive decline in some patients. Analysts say it could become a blockbuster hit.
Full results of Biogen and Eisai's Alzheimer's study on lecanemab give some credence to a controversial hypothesis.
Chris Hemsworth just found out he has a high risk of Alzheimer's, and says watching his grandfather's dementia was 'heartbreaking'
Chris Hemsworth said he learned about his high risk of Alzheimer's while filming, and it prompted him to spend more time with family and work less.
After their father and grandfather died of Alzheimer's, these brothers began exploring how functional and psychedelic mushrooms can impact brain health
After their father and grandfather died of Alzheimer's, they founded a company to better understand how regular and psychedelic mushrooms can help.
A 6-year-old has a rare disease that his mom calls Parkinson's mixed with Alzheimer's. His family hopes a scientific miracle can save his life.
Léo Vauclare was 2 when he got a diagnosis of a rare genetic disease. The life expectancy is five to 10 years, and his family is desperate for a cure.
Years of Alzheimer's research were based on a key finding. Now an investigation alleges it was faked, and the work may have been wasted.
A seminal 2006 paper contains manipulated data, an investigation from Science alleges. More than 2,200 papers refer to this paper in their work.
'Real Housewives of Beverly Hills' star Erika Jayne says Tom Girardi 'still thinks he's practicing law' while at a care facility where his health continues to 'decline'
"It will not get better," Jayne told Andy Cohen of Girardi's health on Wednesday's "Watch What Happens Live."
Medicare sticks by decision to limit coverage of a controversial Alzheimer's drug to people involved in clinical trials
The Medicare coverage decision is a blow for Biogen, which has struggled with sales of its new drug after a controversial FDA approval.
Advertisement
Advertisement
A long-held approach to treating Alzheimer's has disappointed experts. 2 new biotechs think their gene therapies could turn the tide.
Biotechs Lexeo Therapeutics and Shape Therapeutics gave the public its first look at the one-and-done gene therapies they're creating for Alzheimer's.
Biogen bet its Alzheimer’s drug could make billions. Here’s how it all fell apart.
In the first six months of its launch, Biogen's Alzheimer's drug Aduhelm has disappointed Wall Street and been rejected by European regulators.
Why 2022 could be the most crucial year yet for gene editing
These are Insider's biggest healthcare stories for December 21.
Read the FDA report on the death of a woman who was taking a new Alzheimer's drug, reigniting safety concerns
These are Insider's biggest healthcare stories for December 13.
A woman died while taking a controversial new Alzheimer's drug, increasing concerns about its safety. Read the FDA report on what happened.
People taking Biogen's new Alzheimer's drug could have brain swelling. Insider got a copy of the report on a woman who died while taking the drug.